Pharmaceutical company in
Romanshorn

Max Zeller Söhne Aktiengesellschaft

Since 1953 · 21–50 empl.·4.9(15)

Max Zeller Söhne Aktiengesellschaft develops, produces and markets herbal medicines. Its range includes products for various therapeutic areas, other medicines for self-medication and food supplements.

Zeller Medical AG

Since 1996 · 21–50 empl.·4.9(15)

Zeller Medical AG is a subsidiary of Max Zeller Söhne AG and offers a broad portfolio of mainly herbal medicines. Its products are intended to treat gynaecological, urological and dermatological conditions, as well as allergies, coughs, heart conditions and disorders of the central nervous system.

Avosano Industrie Service AG

Since 2002 · 101–500 empl.·4.4(29)

Avosano Industrie Service AG provides pre-wholesale services for the pharmaceutical industry. It handles the storage, processing and distribution of medicines, and offers additional services including order entry, customer service, accounts receivable management, quality control and secondary packaging.

RDP Pharma AG

Since 2019 · 11–20 empl.

RDP Pharma AG is a biotechnology company that researches and develops pharmaceutical agents. It is developing the PromptDegrader® platform for targeted degradation of certain proteins and drug candidates for oncology, including an HPV E7 protein degrader and the orally available alkylether lipid CP201.

RDP PROMPT AG

Since 2022 · 1–10 empl.

RDP PROMPT AG is a privately held biotech company developing therapeutics that identify and degrade intrinsically disordered region (IDR) proteins using the PromptDegrader™ protein modulation platform. Its projects include an E7 degrader targeting the HPV E7 oncoprotein, research on MYC, and other programs such as CROMOC and CP201.

Oserev AG

Since 2026 · 1–10 empl.